arrow
H

Hiroyoshi Nishikawa

national cancer centre japan
H指数:65
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma

按需GLUT3表达增强CAR T细胞在胶质母细胞瘤临床前模型中的代谢适应性和抗肿瘤效果

2026-04-010
PRE
Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease

中性粒细胞植入时CD56+单核细胞的百分比与急性移植物抗宿主病的发生率相关

2026-03-020
OAAI
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

对肿瘤抗原的体液IgG1反应是免疫检查点阻断的临床结果的基础

2026-01-270
OAAI
Mitochondrial DNA abundance is a determinant of immunogenic cell death in cancer

线粒体DNA丰度是癌症中免疫原性细胞死亡的决定因素

Immunity
IF26.3
2026-01-010
OA
Longitudinal remodeling of the tumor-immune microenvironment during regorafenib, nivolumab, and chemotherapy in advanced gastric cancer

在瑞戈菲尼、纳武利尤单抗和化疗过程中,晚期胃癌肿瘤-免疫微环境的纵向重塑

2026-01-010
PRE
Mutation of CMTR2 in Lung Adenocarcinoma Alters RNA Alternative Splicing and Reveals Therapeutic Vulnerabilities

CMTR2基因突变在肺腺癌中改变了RNA选择性剪接并揭示了治疗易感性

2025-11-060
OAAI
KRAS mutations disrupt interactions between CD8+ T cells and antigen-presenting cells in the tumor microenvironment of biliary tract cancer

KRAS突变破坏胆道肿瘤微环境中CD8+ T细胞与抗原呈递细胞之间的相互作用

2025-11-011
PRE
Microbiota-driven antitumour immunity mediated by dendritic cell migration

树突状细胞迁移介导的微生物驱动的抗肿瘤免疫

Nature
IF48.5
2025-07-140
OA
Identification of microenvironment features associated with primary resistance to anti-PD-1/PD-L1+antiangiogenesis in gastric cancer through spatial transcriptomics and plasma proteomics

通过空间转录组学和血浆蛋白质组学鉴定与胃癌anti-PD-1/PD-L1抗血管生成相关的微环境特征

2024-09-131
OAAI
An open label phase II study of lenvatinib with pembrolizumab and FLOT in the neoadjuvant and adjuvant treatment for patients with gastric and gastroesophageal junction adenocarcinoma (EPOC2001)

一项开放标签II期研究,评估lenvatinib联合pembrolizumab和FLOT在胃及胃食管结合部腺癌患者新辅助及辅助治疗中的应用(EPOC2001)。

2024-09-011
PRE
Three-year outcomes of preoperative chemoradiotherapy plus nivolumab in microsatellite stable and microsatellite instability-high locally advanced rectal cancer

术前放化疗联合nivolumab治疗微卫星稳定和微卫星不稳定高位局部晚期直肠癌的三年预后

2024-06-042
PRE
Definitive chemoradiotherapy induces T-cell-inflamed tumor microenvironment in unresectable locally advanced esophageal squamous cell carcinoma

根治性放化疗诱导不可切除的局部晚期食管鳞状细胞癌的T细胞炎性肿瘤微环境

2024-05-310
PRE
Prospective study on eribulin efficacy in advanced and metastatic breast cancer: changes in TGF-β compared to other standard chemotherapy agents (KBCSG-TR 2018, POTENTIAL)
2024-05-020
PRE
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling
2024-04-181
PRE